Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01425944 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 2025 to Feb 9, 2027v15
  2. Primary and study completion dates: Dec 2024 to Dec 2025v14
  3. Primary and study completion dates: Dec 2023 to Dec 2024v13
  4. Primary and study completion dates: Dec 2021 to Dec 2023v12
  5. Primary and study completion dates: Jul 2020 to Dec 2021v11
Show 9 earlier versionsHide 9 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 7 of 7 sites
    v10
  2. Site contacts updated at 1 of 7 sitesv9
  3. Site contacts updated at 1 of 7 sitesv8
  4. Site details revised at 2 of 7 sitesv7
  5. Site details revised at 2 of 7 sitesv6
  6. Enrollment target: 386 to 600v5 Show 5 more changesShow less
    • Primary and study completion dates: Sep 2015 to Jul 2020
    • Study sites: 5 to 7
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 42 words
    • Collaborators: 8 to 10
  7. Enrollment target: 800 to 386
    • Site contacts updated at 2 of 5 sites
    v4
  8. Study sites: 4 to 5v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study has three aims that hope to expand the knowledge on the cause of Sturge-Weber Syndrome (SWS) and improve clinical care of Sturge-Weber Syndrome patients.
Trial Details
NCT Number NCT01425944
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Collaborators: National Institutes of Health (NIH), University of California, San Francisco, National Institute of Neurological Disorders and Stroke (NINDS), Duke University, Children's Hospital of Michigan, Baylor College of Medicine, Wills Eye, Nationwide Children's Hospital, New York University, Children's Hospital Medical Center, Cincinnati
Conditions
(from sponsor)		 Sturge-Weber Syndrome
Related terms Sturge-Weber Syndrome
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov